Christina Kober
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 08, 2023
IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools.
Journal: PloS one
Published: August 17, 2021
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 05, 2021
Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer Agent.
Journal: Theranostics
Published: April 28, 2015
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
Journal: Journal of translational medicine
Published: January 14, 2015
Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.
Journal: Molecular therapy oncolytics
Published: January 01, 2015
Characterization of metastasis formation and virotherapy in the human C33A cervical cancer model.
Journal: PloS one
Published: September 06, 2013
Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer.
Journal: Journal of translational medicine
Published: August 17, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026